Abstract:
ObjectiveTo explore the diagnostic value of SPECT localization and CT-guided percutaneous lung biopsy and tumor markers in peripheral lung cancer.
MethodsA total of 275 patients with peripheral lung neoplasms were retrospectively analyzed. Pathological diagnosis was performed by SPECT with localizable CT-guided lung biopsy. The value of this imaging modality in combination with tumor markers in diagnosing lung cancer was evaluated. T-test or approximate t-test were used for data analysis using SPSS13.0 software.
ResultsAll of the lung biopsies were successful. The sensitivity, specificity, and accuracy for lung cancer diagnosis were 97.01%, 100%, and 97.82%, respectively. No significant difference in carcino-embryonic antigen and CYFRA21-1 values was detected between non-small-cell lung cancer and small-cell lung cancer(t=1.081, 0.666, both P>0.05). However, the neuron-specific enolase(NSE) value of small-cell lung cancer(SCLC) was significantly higher than that of non-small-cell lung cancer(NSCLC), and the difference was statistically significant(t=3.671, P < 0.05). The area under the receiver operating curve of NSE was 0.935. The cut-off value of the diagnostic critical of NSE was 26.86 ng/mL, with a sensitivity of 91.34% and specificity of 84.92%.
ConclusionsSPECT with localizable CT-guided percutaneous lung biopsy is feasible and highly accurate for diagnosis of peripheral lung cancer. In addition, NSE is useful in the identification of SCLC and NSCLC.